Pharma Industry
Industry: Email Alert RSS FeedTaro receives approval for generic bactroban ointment
Journal of Drugs in Dermatology, Jan, 2006
Taro Pharmaceutical Industries, Ltd., received FDA approval to market mupirocin, a generic version of GlaxoSmithKline's bactroban ointment. This ointment is commonly used to treat mild skin infections due to staphylococcus aureus.
Most RecentPharma Articles
- Noven's Brandt Pockets $2.4M in Hisamitsu Buy, Just 15 Months Into the Job
- Analysts Rain on Lilly's Effient Parade; 70% of Sales Go Generic After 2011
- Doctors May Not All Be Big Pharma's Friends in Healthcare Reform Debate
- UPDATED: Pfizer Accused of "Bribe" to Stave Off Price Control Law in Philippines
- Merck KGaA on Cancer Vaccines: We're Not Crazy, Just Convinced
- More »
COPYRIGHT 2006 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
Brought to you by CBS MoneyWatch.com
- 10 Best Places to Retire
- Companies with the Best 401(k) Plans
- Most Important Document for Your Heirs? It's Not Your Will
- Video: Should You Expect to Retire Rich?
- Over 50? Here's How to Get (and Keep) a Great Job
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- La anemia falciforme - causas y tratamiento
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
Most Popular Health Publications
Content provided in partnership with
